Pediatric atypical hemolytic–uremic syndrome due to auto-antibodies against factor H: is there an interest to combine eculizumab and mycophenolate mofetil?
Lucie Matrat, Justine Bacchetta, Bruno Ranchin, Corentin Tanné, Anne‐Laure Sellier‐Leclerc
Topics & Concepts
EculizumabAtypical hemolytic uremic syndromeMedicineThrombotic microangiopathyAlternative complement pathwayComplement component 5ImmunologyMycophenolateInternal medicineNephrologyAntibodyMycophenolic acidGastroenterologyComplement systemTransplantationDiseaseComplement system in diseasesBlood groups and transfusionEscherichia coli research studies